With tanker traffic through the strait dropping by 90%, it's not hard to draw a straight line between the ongoing conflict and widespread supply chain disruptions.
Companies remain caught between a court ruling that invalidated the tariffs, and a government that has yet to fully acknowledge how it intends to unwind them.
With all the fancy predictive analytics that firms have adopted in recent years, why are they still slow to respond once they know a disruption is coming down the line?
GLP-1 drugs are forcing companies to adapt to a sustained shift in consumer behavior and healthcare demand that touches both food and pharma supply chains.